GLP-1 medications like Ozempic, Wegovy and Mounjaro have become something of a cultural lightning rod over the past few years ...

An experimental obesity pill from Structure Therapeutics helped patients lose significant weight in a mid-stage trial, with a ...

The small study, published recently in the journal Obesity, looked at 34 patients who had already lost weight on GLP-1 ...

Uncrowned is a new destination for all things MMA, boxing, wrestling, and more, featuring Ariel Helwani. But injectable medications aren’t right for everyone. That’s where a new wave of oral GLP-1 ...

The results of this obesity medication are literally eye-popping. A new review of adverse effects reports to the FDA between the years 2017 and 2024 reveals that Ozempic and Wegovy have both been ...

By Andrew Silver SHANGHAI, March 6 (Reuters) - China has approved Pfizer's GLP-1 treatment Xianweiying for long-term weight ...

Add Yahoo as a preferred source to see more of our stories on Google. CEO Sam Tejada, and CMO Dr. Christopher Davis of 'Liquivida' stopped by the KTLA Weekend Morning News to explain the difference ...

Wegovy pill, the first FDA‑approved oral GLP‑1 for weight loss, is now available via WeightWatchers Med+ from $149 per month ...

GoodRx reports that GLP-1 medications will expand in use and accessibility, with new oral options and evolving insurance ...

Eli Lilly has issued a new warning against buying compounded versions of its drug tirzepatide, claiming to have found potentially dangerous impurities.

Research led by Penn Dental's Henry Daniell investigates the use of a lettuce-based, plant-encapsulated delivery platform as ...

In a recent review, a small group of patients received the injections less frequently but still maintained weight loss and ...